Publication | Closed Access

Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting

ThrombosisCardiovascular DiseaseBlood PlateletPlatelet InhibitionAcute Coronary SyndromePharmacotherapyPlatelet AntagonistMedicineAnticoagulantCardiologyEmergency MedicineAcute Myocardial Infarction